IPPRA / Grant Monitor

2026-07-07
← Board

DoW Neurofibromatosis Investigator-Initiated Research Award

HT942526NFRPIIRA · Defense Health Agency Contracting Activity - DHACA

biomedical clinical ai data science public health Science & Technology R&D

Closes
2026-09-22 · 77 d
Award ceiling
Award floor
Program funding
$6,040,000
Expected awards
7
Cost sharing
No
Posted
2026-06-25
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

Funds investigator-initiated neurofibromatosis research projects with preliminary and/or published NF-relevant data, excluding clinical trials, for eligible applicants under the FY26 NFRP mechanism.

Funds
applied research
University
unclear
social behavioral
minor
physical sciences
minor
engineering
minor
life biomedical
central
computational data
substantial

⚑ Clinical trials are excluded. · Requires preliminary and/or published data relevant to neurofibromatosis. · Optional Open Science Initiative emphasizes early access to and sharing of data. · Optional Qualified Collaborator is a funding-level feature, not a separate eligibility class.

Unit fits — one characterization, each unit's own rules

Physical Sciences & Engineering (demo) 65 good technical depth: substantial; funds applied research
IPPRA 53 partial peripheral portfolio topic: public_health; social/behavioral work is minor; funds applied research; eligibility unclear — verify in the NOFO; biomedical core — IPPRA health lane is communication/crisis/policy (capped)
Tom Love Innovation Hub 30 weak funds applied research; deep-tech content

Description

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Investigator-Initiated Research Award (IIRA) supports high-impact research that addresses a critical need and has the potential to make important contributions to the field of neurofibromatosis disorders or advance patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.

Distinctive Features: This award mechanism offers two funding levels based on participation in two optional features:

• Open Science Initiative: Catalyzes research for neurofibromatosis through early access to data and data sharing within the neurofibromatosis community.

• Optional Qualified Collaborator: Encourages collaborative research between basic scientists and clinical researchers, and between academic and biotechnology scientists.

The funding levels are defined as follows:

• Level 1: Applications without an optional feature.

• Level 2: Applications including one of the optional features.

Apply

View on Grants.gov → CONTACT: Ebony S Simmons Grantor <help@eBRAP.org>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · Department of Defense (BAA-style) conventions SEE A DOD EXAMPLE →

Funder-faithful document skeletons — Department of Defense (BAA-style)'s document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING